ROARABLE
FREE $100K
My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / LFWD / dividends
HSCS (38) CUPR (21) CLGN (41) MLSS (40) ⌘ Pro Terminal →

Lifeward Ltd. (LFWD) Dividend Safety Gauge & 10-Year DRIP Compounder

$6.06 +1.82% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.07

Lifeward Ltd. (LFWD) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $16.9M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on LFWD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is LFWD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Lifeward Ltd. (NASDAQ: LFWD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $6.06 (+1.82% 1D, market cap $16.9M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, LFWD ranks #736 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does LFWD compare to HSCS and CUPR in the Health Care sector?
▼

Within the Health Care sector (Industrial Specialties), LFWD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, HSCS (HeartSciences Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M) and CUPR (Cuprina Holdings (Cayman) Limited (Class A)) posts a E grade (21/100 RQD, P/E N/A, ROIC -35.0%, cap $13.5M). Among the 5-stock peer group, MLSS leads on earnings multiple (5.0x) while LFWD leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for LFWD?
▼

Per LFWD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001607962), Lifeward Ltd. generated $1.4M in revenue (-17.6% YoY), -$19.9M in net income, and -$16.8M in free cash flow against $22.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $6.07 (+0.14%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510032
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk D-
Cash (6)Whales (5)SEC (10)Macro (6)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-11.7% Base Target
$10 Bull$5 Base$4 Bear
📬 FREE LFWD RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFWD)Realized 20D OHLCV Swing Band: ±9.9%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY LFWD SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (31% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Cash Engine Quality+6/20 pts (19% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 602% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
40
Grade D$6.10-8% Next Q
Q2 (-2Q)
37
Grade E$5.61+7.7% Next Q
Q3 (-1Q)
35
Grade E$6.04+0.3% Next Q
Current
32
Grade E$6.06-9.2% Hist 90D α
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a LFWD Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While LFWD currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.61) and Max Pain ($6.36) forces dealer call-delta covering toward $10.09.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFWD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LFWD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 32%NO 68%Trade / Inspect Odds →
CASH DIVIDEND + BUYBACK YIELD
1.8% Total Yield
0% Cash ($0.00/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 • REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr
$10.6K
Yr 1
$11.1K
Yr 2
$11.7K
Yr 3
$12.4K
Yr 4
$13.1K
Yr 5
$13.8K
Yr 6
$14.5K
Yr 7
$15.3K
Yr 8
$16.2K
Yr 9
$17.1K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFWD)

  • ✓Walkthrough of LFWD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
LFWD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -14.29%📐 HORIZONTAL RANGE
2026-11-03O $5.91H $6.06L $5.91C $6.06VOL 3.5K
RES: $8.00SUP: $4.40SMA50: $6.61SMA200: $6.94
$9.92$8.64$7.35$6.07$4.78RES $8.00SUP $4.40$6.062026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LFWD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 LFWD Butterfly Map → + Track LFWD →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -17.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on LFWD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for LFWD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LFWD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFWD)

Health Care Rank #736 of 1015 ⚔️ HSCS vs LFWD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (LFWD vs. HSCS, CUPR, CLGN, MLSS)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Lifeward Ltd. (LFWD) ranks #736 by composite RQD confidence (32/100, grade E) and #840 by equity capitalization ($16.9M). Within this direct 5-issuer industry benchmark cohort, MLSS leads on earnings valuation at 5.0x trailing P/E, while LFWD leads on capital efficiency and profitability with -35.0% ROIC and 96.0% gross margin. CLGN currently holds the highest overall quantitative score in the immediate peer group at 41/100 (D-) compared with LFWD at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
LFWD ACTIVE
Lifeward Ltd.
E 32/100 — 96.0% -35.0% +1.82% $16.9M Benchmark Subject
HSCS
HeartSciences Inc.
D- 38/100 — 59.1% -35.0% -9.67% $16.0M /hscs-vs-lfwd →
CUPR
Cuprina Holdings (Cayman) Limited (Class A)
E 21/100 — -1.3% -35.0% +3.96% $13.5M /cupr-vs-lfwd →
CLGN
CollPlant Biotechnologies Ltd
D- 41/100 — 64.8% -35.0% -1.33% $11.9M /clgn-vs-lfwd →
MLSS
Milestone Scientific Inc.
D- 40/100 5.0x 71.4% -35.0% +5.88% $27.6M /mlss-vs-lfwd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001607962 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Lifeward Ltd. (LFWD) reported GAAP revenue of $1.4M (-17.6% vs. FY2024 revenue of $1.7M , and +221.8% cumulative change since FY2023) , GAAP net income of -$19.9M, operating cash flow of -$16.8M, and free cash flow of -$16.8M (+22.5% YoY). On the balance sheet, LFWD closed FY2025 with $22.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $1.4M -$19.9M -$16.8M -$16.8M $22.9M —
FY2024 (FY) 2024-12-31 $1.7M -$28.9M -$21.7M -$21.7M $30.5M —
FY2023 (FY) 2023-12-31 $435.0K -$22.1M -$20.7M -$20.7M — —

3. LFWD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LFWD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Lifeward Ltd. (NASDAQ: LFWD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $6.06 (+1.82% 1D, market cap $16.9M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, LFWD ranks #736 in composite RQD confidence.

How does LFWD compare to HSCS and CUPR in the Health Care sector?

Within the Health Care sector (Industrial Specialties), LFWD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, HSCS (HeartSciences Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M) and CUPR (Cuprina Holdings (Cayman) Limited (Class A)) posts a E grade (21/100 RQD, P/E N/A, ROIC -35.0%, cap $13.5M). Among the 5-stock peer group, MLSS leads on earnings multiple (5.0x) while LFWD leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for LFWD?

Per LFWD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001607962), Lifeward Ltd. generated $1.4M in revenue (-17.6% YoY), -$19.9M in net income, and -$16.8M in free cash flow against $22.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is LFWD trading relative to its 50-day, 200-day, and 52-week technical levels?

LFWD last traded at $6.06 (+1.82% on volume of 94,506 shares), positioning the stock -8.32% below its 50-day simple moving average ($6.61) and -12.68% below its 200-day simple moving average ($6.94). Across its 52-week range of $4.14 to $9.61, LFWD sits at the 35.1% percentile with a 14-day RSI of 45.1 (NEUTRAL RANGE) and an implied next-earnings move of ±9.9% ($5.46 to $6.66).

Direct Sub-Reports: LFWD RQD Cockpit LFWD 12M Forecast LFWD Earnings & Move LFWD Dividends & DRIP LFWD Insiders & 13F LFWD Whale Options LFWD Profit Sankey LFWD News & Why
ROARABLE RATING BRIEF • RQD 32/100 (E) ✓ SEC XBRL & RQD VERIFIED

LFWD — Lifeward Ltd.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Lifeward Ltd. (LFWD) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $6.06 (+1.82% 1D, market capitalization $16.9M).

  • Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 96.0%, operating margin of -60.0%, and free cash flow yield of —.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (6/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Lifeward Ltd. Is a NASDAQ-listed issuer in the Health Care sector, within the Industrial Specialties industry,. The source does not describe its products, customers, or revenue model in detail. The SEC financials show reported revenue of $1.4M in FY 2025, $1.7M in FY 2024, and $0.4M in FY 2023. The news wire references the ReWalk® Personal Exoskeleton, indicating the company's product focus.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Lifeward Ltd. (LFWD) reported $1.4M in annual revenue (up from $1.7M in FY2024, -17.6% YoY) and -$19.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($435.0K revenue, -$22.1M net income) through FY2025, LFWD scaled operating cash flow to -$16.8M and free cash flow to -$16.8M, backed by $22.9M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (E • RQD 32/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 5/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $4.14 – $9.61 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies, sector correlations, and second-order bottlenecks cannot be mapped from the source data. A prospective investor should watch for finance-leadership continuity given the interim arrangement referenced in the news wire, and for cash-runway implications given the decline in reported cash.

  • Key Question #1: Can LFWD sustain or expand its -60.0% operating margin and -35.0% ROIC against Industrial Specialties peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $1.4M and free cash flow of -$16.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is LFWD's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

LFWD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Lifeward Ltd. (LFWD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to LFWD Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

LFWD Bull vs. Bear Conversation Board — What's Your Call at $6.06?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON LFWD 🐻 33% BEARISH CONVICTION
1. Pick Your Side on LFWD:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $7.32 (+23.0%)
📌 Pinned Debate

The forensic balance-sheet pillar is the strongest in the rating, at 10 of 20, supported by an Altman Z of 2.5 and Debt/Equity of 0.5.

The street is overcomplicating Lifeward Ltd. (LFWD). The forensic balance-sheet pillar is the strongest in the rating, at 10 of 20, supported by an Altman Z of 2.5 and Debt/Equity of 0.5.. With an RQD score of 32/100 (E) and Forensic Balance Sheet at 10/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $6.43.

SectorRotator 🐂 BULL

@SiliconVal_Bull Agree on the RQD 32/100 quality, though with 1.0 beta I'm scaling in with half-size at $5.95 and keeping dry powder in case we test $5.53.

SK SkepticalCFA RQD DEBATE OPENER • Fundamental Contrarian 🐻 BEARISH 🎯 Target: $4.76 (-20.0%)
Spot @ $5.95

Reported operating and net losses with negative free cash flow in every period shown, and ROIC of -35%, point to a business that is not

Reported operating and net losses with negative free cash flow in every period shown, and ROIC of -35%, point to a business that is not self-funding.. Look at the math on LFWD: paying current EV/EBITDA multiples for -35.0% ROIC and -60.0% operating margins leaves zero margin of safety if Industrial Specialties demand softens. I'd wait for a retest of $5.24 before getting long.

LIVE TAPE